Kuehne & Nagel (KNIN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 224.10 |
|---|---|
| 52-week range | 148.90 – 235.00 |
| Return, 1 month / 3 months | −3.1% / +7.7% |
| Return, 1 year / 3 years | +49.4% / −1.2% |
| Trend | Uptrend |
| RSI (14) | 49 |
| Volatility (1 year) | 27.9% |
| Worst drawdown (1 year) | -13.6% |
| Average daily value traded | 51.96M CHF |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kuehne + Nagel is a logistics company based in Switzerland that arranges the movement of goods for businesses around the world. Its main services are sea freight and air freight forwarding, where it organises shipments and handles customs and documentation for customers. It also runs contract logistics operations, including warehousing and distribution, for manufacturers, retailers and other companies that need their goods stored and moved.
On this site Kuehne & Nagel appears as a stock on the SIX Swiss Exchange (Switzerland), code KNIN, with prices in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kuehne & Nagel (KNIN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 224.10 on 22 October 2026.
Its price-based Market X-Ray is 78 out of 100 (a strong price profile), ranking 6 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 49.4% and over the last three months it rose 7.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 85 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 16.7% | ||
| From 52-week high | -3.3% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 7.7% | ||
| 6-month return | 20.8% | ||
| 12-month return, skipping the last month | 54.1% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.6% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 51.96M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 58 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.9% |
|---|---|
| 1 month | −3.1% |
| 3 months | +7.7% |
| 6 months | +20.8% |
| 1 year | +49.4% |
| 3 years | −1.2% |
| 5 years | −9.6% |
Signals
| 50-day / 200-day average | 220.72 / 191.98 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.02 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2026 | CHF 6.0000 |
| 9 May 2025 | CHF 8.2500 |
| 10 May 2024 | CHF 1.7500 |
| 11 May 2023 | CHF 14.0000 |
| 5 May 2022 | CHF 10.0000 |
| 6 May 2021 | CHF 4.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.